Inverness Counsel’s Medtronic MDT Stock Holding History

Inverness Counsel’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$428K	Buy	5,298 +448	+9%	+$40.3K	0.02%	133
2022 Q2	$435K	Sell	4,850 -17	-0.3%	-$1.72K	0.02%	125
2022 Q1	$540K	Buy	4,867 +2,535	+109%	+$268K	0.02%	119
2021 Q4	$241K	Sell	2,332 -1,190	-34%	-$138K	0.01%	176
2021 Q3	$441K	Buy	3,522 +1,713	+95%	+$222K	0.02%	126
2021 Q2	$225K	Buy	+1,809	New	+$227K	0.01%	163
2015 Q2	–	Sell	-2,870	Closed	-$224K	–	113
2015 Q1	$224K	Hold	2,870	–	–	0.02%	104
2014 Q4	$207K	Sell	2,870 -1,432	-33%	-$99.5K	0.02%	109
2014 Q3	$267K	Buy	+4,302	New	+$274K	0.02%	102

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Inverness Counsel's MDT Position: Q3 2022 in Review

Inverness Counsel increased its Medtronic (MDT) stake by 9.2% in Q3 2022, buying an estimated $40.3K and bringing the position to 5,298 shares worth $428K. The position accounts for 0.02% of the portfolio, ranked #133.

Inverness Counsel first reported a position in MDT in Q3 2014 and has held it in 9 quarters since. The position peaked at $540K in Q1 2022. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

Inverness Counsel held 5,298 shares of Medtronic worth $428K as of Q3 2022.
Inverness Counsel bought 448 Medtronic shares in Q3 2022, an estimated $40.3K.
Medtronic made up 0.02% of Inverness Counsel's portfolio in Q3 2022, its #133 holding.
Inverness Counsel first reported a position in Medtronic in Q3 2014 and has held it in 9 quarters since.
Inverness Counsel's Medtronic position peaked at $540K in Q1 2022.
1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.